Hancock Whitney’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Sell |
8,752
-252
| -3% | -$52.4K | 0.03% | 315 |
|
|
2026
Q1 | $1.75M | Sell |
9,004
-288
| -3% | -$62K | 0.03% | 332 |
|
|
2025
Q4 | $1.91M | Buy |
9,292
+6
| +0.1% | +$1.13K | 0.03% | 306 |
|
|
2025
Q3 | $1.46M | Sell |
9,286
-338
| -4% | -$52.2K | 0.03% | 350 |
|
|
2025
Q2 | $1.62M | Buy |
9,624
+585
| +6% | +$86.8K | 0.03% | 328 |
|
|
2025
Q1 | $1.25M | Sell |
9,039
-11,425
| -56% | -$1.46M | 0.04% | 277 |
|
|
2024
Q4 | $2.42M | Sell |
20,464
-739
| -3% | -$86.3K | 0.08% | 176 |
|
|
2024
Q3 | $2.34M | Sell |
21,203
-1,643
| -7% | -$172K | 0.08% | 178 |
|
|
2024
Q2 | $2.25M | Sell |
22,846
-144,118
| -86% | -$14.7M | 0.08% | 176 |
|
|
2024
Q1 | $18.7M | Buy |
166,964
+98,517
| +144% | +$10.6M | 0.65% | 33 |
|
|
2023
Q4 | $6.9M | Buy |
68,447
+63,030
| +1,164% | +$6.25M | 0.26% | 86 |
|
|
2023
Q3 | $470K | Sell |
5,417
-297
| -5% | -$26.8K | 0.02% | 437 |
|
|
2023
Q2 | $540K | Buy |
5,714
+602
| +12% | +$50.9K | 0.02% | 427 |
|
|
2023
Q1 | $386K | Sell |
5,112
-899
| -15% | -$67.8K | 0.02% | 485 |
|
|
2022
Q4 | $462K | Buy |
6,011
+469
| +8% | +$35.6K | 0.02% | 443 |
|
|
2022
Q3 | $370K | Sell |
5,542
-287
| -5% | -$18.2K | 0.02% | 475 |
|
|
2022
Q2 | $305K | Sell |
5,829
-670
| -10% | -$38.1K | 0.01% | 547 |
|
|
2022
Q1 | $368K | Buy |
6,499
+295
| +5% | +$15.8K | 0.01% | 537 |
|
|
2021
Q4 | $319K | Buy |
6,204
+291
| +5% | +$14.3K | 0.01% | 576 |
|
|
2021
Q3 | $292K | Sell |
5,913
-2,990
| -34% | -$162K | 0.01% | 574 |
|
|
2021
Q2 | $508K | Sell |
8,903
-792
| -8% | -$46.3K | 0.02% | 543 |
|
|
2021
Q1 | $589K | Sell |
9,695
-88
| -0.9% | -$4.86K | 0.02% | 505 |
|
|
2020
Q4 | $524K | Sell |
9,783
-38,411
| -80% | -$1.99M | 0.02% | 515 |
|
|
2020
Q3 | $2.26M | Sell |
48,194
-5,705
| -11% | -$293K | 0.08% | 200 |
|
|
2020
Q2 | $2.81M | Sell |
53,899
-17,651
| -25% | -$910K | 0.11% | 164 |
|
|
2020
Q1 | $3.43M | Buy |
71,550
+16,635
| +30% | +$864K | 0.13% | 173 |
|
|
2019
Q4 | $2.78M | Sell |
54,915
-298
| -0.5% | -$15.4K | 0.09% | 251 |
|
|
2019
Q3 | $2.6M | Buy |
55,213
+12,822
| +30% | +$585K | 0.09% | 260 |
|
|
2019
Q2 | $2M | Sell |
42,391
-799
| -2% | -$36.9K | 0.06% | 300 |
|
|
2019
Q1 | $2.08M | Buy |
43,190
+34,380
| +390% | +$1.72M | 0.07% | 297 |
|
|
2018
Q4 | $393K | Sell |
8,810
-80
| -0.9% | -$4.17K | 0.01% | 655 |
|
|
2018
Q3 | $480K | Buy |
+8,890
| New | +$455K | 0.01% | 654 |
|
|
2016
Q2 | – | Sell |
-11,371
| Closed | -$932 | – | 574 |
|
|
2016
Q1 | $932 | Buy |
11,371
+135
| +1% | +$11K | 0.04% | 314 |
|
|
2015
Q4 | $1M | Buy |
+11,236
| New | +$954K | 0.04% | 292 |
|
|
2014
Q3 | – | Sell |
-9,770
| Closed | -$670K | – | 497 |
|
|
2014
Q2 | $670K | Hold |
9,770
| – | – | 0.02% | 321 |
|
|
2014
Q1 | $684K | Hold |
9,770
| – | – | 0.03% | 314 |
|
|
2013
Q4 | $653K | Hold |
9,770
| – | – | 0.03% | 309 |
|
|
2013
Q3 | $510K | Sell |
9,770
-600
| -6% | -$30.5K | 0.02% | 333 |
|
|
2013
Q2 | $489K | Buy |
+10,370
| New | +$474K | 0.02% | 346 |
|
Other funds holding CAH
Hancock Whitney's CAH Position: Q2 2026 in Review
Hancock Whitney reduced its Cardinal Health (CAH) stake by 2.8% in Q2 2026, selling an estimated $52.4K and leaving 8,752 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #315.
Hancock Whitney first reported a position in CAH in Q2 2013 and has held it in 39 quarters since. The position peaked at $18.7M in Q1 2024. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Hancock Whitney held 8,752 shares of Cardinal Health worth $2.08M as of Q2 2026.
- Hancock Whitney sold 252 Cardinal Health shares in Q2 2026, an estimated $52.4K.
- Cardinal Health made up 0.03% of Hancock Whitney's portfolio in Q2 2026, its #315 holding.
- Hancock Whitney first reported a position in Cardinal Health in Q2 2013 and has held it in 39 quarters since.
- Hancock Whitney's Cardinal Health position peaked at $18.7M in Q1 2024.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.